Cargando…
Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene Therapy
Pancreatic cancer is an aggressive disease and the fourth most lethal cancer in developed countries. Despite all progress in medicine and in understanding the molecular mechanisms of carcinogenesis, pancreatic cancer still has a poor prognosis, the median survival after diagnosis being around 3 to 6...
Autores principales: | Passadouro, Marta, Faneca, Henrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881540/ https://www.ncbi.nlm.nih.gov/pubmed/27187371 http://dx.doi.org/10.3390/ijms17050718 |
Ejemplares similares
-
MicroRNA modulation combined with sunitinib as a novel therapeutic strategy for pancreatic cancer
por: Passadouro, Marta, et al.
Publicado: (2014) -
The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster
por: Yonemori, Keiichi, et al.
Publicado: (2017) -
MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
por: Brunetti, Oronzo, et al.
Publicado: (2015) -
microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells
por: Mortoglou, Maria, et al.
Publicado: (2022) -
MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II
por: Dhayat, Sameer Abdallah, et al.
Publicado: (2015)